Phase 2 Study of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) (Enlarged Prostate)

Completed · Phase 2

Conditions studied: Benign Prostatic Hyperplasia (BPH), Enlarged Prostate

In brief

This completed study evaluated the safety and efficacy of two dose levels of NX-1207 for the treatment of BPH (benign prostatic hyperplasia) versus finasteride.

Key facts

Study ID

NCT00759135

Run by

Nymox Corporation

People needed

85

Starts

2007-05-01

Expected to finish

2008-05-01

Last updated by the study team

2012-06-14

Who can join

Age: 45 and older, up to 75. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• Documented history of BPH for at least 1 year
• AUA SI ≥ 15
• Prostate Volume ≥ 30 mL ≤ 70 mL
• Qmax < 15 mL/sec

You may not qualify if…

• History of illness or condition that may interfere with study or endanger subject
• Use of prescribed medications that may interfere with study or endanger subject
• Presence of a median lobe of the prostate
• Surgery or MIST in the previous 12 months for treatment of BPH
• Post-void residual urine volume > 350 mL
• PSA ≥ 10 ng/mL; prostate cancer must be ruled out for PSA ≥ 4 ng/mL

Where it is running

• Nymox Investigational Site — Huntsville, Alabama, United States
• Nymox Investigational Site — Tucson, Arizona, United States
• Nymox Investigational Site — Little Rock, Arkansas, United States
• Nymox Investigational Site — Anaheim, California, United States
• Nymox Investigational Site — Atherton, California, United States
• Nymox Investigational Site — Long Beach, California, United States
• Nymox Investigational Site — Modesto, California, United States
• Nymox Investigational Site — Newport Beach, California, United States
• Nymox Investigational Site — Denver, Colorado, United States
• Nymox Investigational Site — New Britain, Connecticut, United States
• Nymox Investigational Site — Sarasota, Florida, United States
• Nymox Investigational Site — Greenwood, Indiana, United States
• Nymox Investigational Site — Jeffersonville, Indiana, United States
• Nymox Investigational Site — Shreveport, Louisiana, United States
• Nymox Investigational Site — Missoula, Montana, United States
• Nymox Investigational Site — Las Vegas, Nevada, United States
• Nymox Investigational Site — Lawrenceville, New Jersey, United States
• Nymox Investigational Site — Marlton, New Jersey, United States
• Nymox Investigational Site — Voorhees Township, New Jersey, United States
• Nymox Investigational Site — Garden City, New York, United States
• Nymox Investigational Site — Poughkeepsie, New York, United States
• Nymox Investigational Site — Staten Island, New York, United States
• Nymox Investigational Site — Lancaster, Pennsylvania, United States
• Nymox Investigational Site — Myrtle Beach, South Carolina, United States
• Nymox Investigational Site — Germantown, Tennessee, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.